Surufatinib Combined With Chemotherapy Plus Toripalimab or Not in the Treatment of Small Cell Lung Cancer

NCT04996771 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

88

Enrollment

OTHER

Sponsor class

Conditions

Small Cell Lung Carcinoma

Interventions

DRUG: Surufatinib,Etoposide,Cisplatin,Toripalimab
DRUG: Surufatinib,Etoposide,Cisplatin

Sponsor

Sun Yat-sen University